Department of Medicine, Division of Endocrinology and Metabolism, UC San Diego School of Medicine, La Jolla, CA, USA.
Climacteric. 2024 Feb;27(1):5-15. doi: 10.1080/13697137.2023.2259793. Epub 2024 Jan 15.
Cardiovascular disease (CVD) is the leading cause of death for women across the developed and developing world. Beyond traditional cardiovascular risk factors, a number of reproductive milestones have been recognized. The goal of this White Paper, issued by the International Menopause Society in conjunction with World Menopause Day 2023, is to highlight female reproductive milestones in terms of potential cardiovascular risk and to review recommendations for minimizing that risk. The primary milestones discussed relate to menstrual cyclicity, adverse pregnancy outcomes, breast cancer treatments and menopause. Each of these categories has a number of permutations that have been shown in observational studies to be associated with increased cardiovascular risks. In current clinical care, recognition of these reproductive milestones has been encouraged so patients can be informed and motivated to engage in primary prevention of CVD early in their life course rather than retrospectively later in life. Options for specifically targeted care with specialist teams are designed to enhance success with risk identification, screening and possible detection of CVD and, optimally, primary or secondary prevention of CVD. Promoting cardiovascular health of women has far-reaching effects for themselves, their families and their progeny. It is time to make women's cardiovascular health a priority.
心血管疾病(CVD)是发达和发展中国家女性的主要死因。除了传统的心血管危险因素外,许多生殖里程碑已经得到认可。本白皮书由国际绝经学会与 2023 年世界绝经日联合发布,旨在强调女性生殖里程碑与潜在心血管风险的关系,并回顾减少这种风险的建议。主要讨论的里程碑与月经周期、不良妊娠结局、乳腺癌治疗和绝经有关。这些类别中的每一个都有许多组合,观察性研究表明这些组合与心血管风险增加有关。在当前的临床护理中,已经鼓励认识到这些生殖里程碑,以便患者能够了解并积极主动地在其生命早期进行 CVD 的一级预防,而不是在以后的生活中回顾性地进行。与专家团队合作的特定针对性护理方案旨在提高风险识别、筛查和 CVD 可能检测的成功率,并优化 CVD 的一级或二级预防。促进女性的心血管健康对她们自己、她们的家庭和后代都有深远的影响。现在是将女性的心血管健康作为优先事项的时候了。